Appointment of Chief Commercial Officer: Avalo Therapeutics Inc. (AVTX) Bullish After Hours
Gule Rukhsar
January 12, 2022
On January 10, Avalo Therapeutics Inc. (AVTX) announced the appointment of Stephen Smolinski as its Chief Commercial Officer. Following the news, the stock became bullish